ANDRES v. TAKEDA PHARMACEUTICALS AMERICA, INC.

CourtDistrict Court, W.D. Pennsylvania
DecidedOctober 31, 2024
Docket2:24-cv-00920
StatusUnknown

This text of ANDRES v. TAKEDA PHARMACEUTICALS AMERICA, INC. (ANDRES v. TAKEDA PHARMACEUTICALS AMERICA, INC.) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ANDRES v. TAKEDA PHARMACEUTICALS AMERICA, INC., (W.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA PITTSBURGH

KAYLA ANDRES, ) )

) 2:24-CV-00920-MJH Plaintiff, )

) vs. )

) TAKEDA PHARMACEUTICALS ) AMERICA, INC., )

Defendant,

MEMORANDUM OPINION On May 28, 2024, Plaintiff, Kayla Andres filed the initial complaint in this matter in the Court of Common Pleas of Washington County, asserting claims under the Pennsylvania Human Relations Act (“PHRA”). On June 25, 2024, Defendant, Takeda Pharmaceuticals America, Inc., (“Takeda”) removed the matter to this Court. (ECF No. 1). On August 15, 2024, Ms. Andres filed an Amended Complaint, in which she brings two claims under the PHRA. (ECF No. 10). On August 26, 2024, Takeda filed a Motion to Dismiss Ms. Andres’ Amended Complaint and accompanying brief. (ECF Nos. 11 & 12). On September 9, 2024, Ms. Andres filed a Brief in Opposition to Takeda’s Motion to Dismiss. (ECF No. 14). On September 16, 2024, Takeda filed a Reply. (ECF No. 15). The issues in this matter are fully briefed and ripe for disposition. For the following reasons, Takeda’s Motion to Dismiss will be granted. I. Statement of Facts On June 6, 2020. Plaintiff, Kayla Andres, began working for Takeda as a Field Sales Representative in Pittsburgh, Pennsylvania. (ECF No. 10, at ¶¶ 12-13). On September 10, 2021, Takeda initiated a vaccination mandate on its employees who called on customers or patients. (ECF No. 12-1). Takeda employees were required to be fully vaccinated against COVID-19 by November 1, 2021. (Id.). On September 24, 2021, Ms. Andres submitted a religious exemption request from the vaccine mandate. (ECF No. 10, at ¶ 17). On October 14, 2021, Takeda denied Ms. Andres’ religious exemption request, and her employment was terminated on November 5,

2021. (Id. ¶ 18). Ms. Andres alleges that some individuals, who had submitted medical exemption requests, were permitted to work remotely. (Id. ¶ 19). Ms. Andres’ termination letter indicated that her exemption request was denied, because her position required face-to-face interaction, and she could not work remotely. (Id. ¶ 20). After her termination, Ms. Andres applied for three remote positions at Takeda. (Id. ¶ 22). On March 16, 2022, she applied for a Patient Recruitment and

Retention Lead position. (Id. ¶ 23). On March 17, 2022, she applied for a Diversity, Equity, and Inclusion Operations Coordinator position. (Id. ¶ 24). On April 18, 2022, Ms. Andres applied for a Neuroscience Business Unit Complaint Operations Lead position. (Id. ¶ 25). Ms. Andres alleges that she was well qualified for all of these positions and that Takeda ultimately chose less-qualified individuals for the positions or simply closed the positions so they did not have to hire Ms. Andres. (Id. ¶¶ 26-27). II. Relevant Legal Standard

When reviewing a motion to dismiss pursuant to Federal Rule of Civil Procedure 12(b)(6), the court must “accept all factual allegations as true, construe the complaint in the light most favorable to the plaintiff, and determine whether, under any reasonable reading of the complaint, the plaintiff may be entitled to relief.” Eid v. Thompson, 740 F.3d 118, 122 (3d Cir. 2014) (quoting Phillips v. Cty. of Allegheny, 515 F.3d 224, 233 (3d Cir. 2008)). “To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). The Supreme Court clarified that this plausibility standard should not be conflated with a higher probability standard. Iqbal, 556 U.S. at 678. “A claim has facial plausibility when the

plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Iqbal, 556 U.S. at 678 (citing Twombly, 550 U.S. at 556); see also Thompson v. Real Estate Mortg. Network, 748 F.3d 142, 147 (3d Cir. 2014). “Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Iqbal, 556 U.S. at 678. “Factual allegations of a complaint must be enough to raise a right to relief above the speculative level.” Twombly, 550 U.S. at 555. A pleading party need not establish the elements of a prima facie case at this stage; the party must only “put forth allegations that ‘raise a reasonable expectation that discovery will reveal evidence of the necessary element[s].’” Fowler v. UPMC Shadyside, 578 F.3d 203, 213 (3d Cir.

2009) (quoting Graff v. Subbiah Cardiology Assocs., Ltd., 2008 WL 2312671 (W.D. Pa. June 4, 2008)); see also Connelly v. Lane Constr. Corp., 809 F.3d 780, 790 (3d Cir. 2016). Nonetheless, a court need not credit bald assertions, unwarranted inferences, or legal conclusions cast in the form of factual averments. Morse v. Lower Merion Sch. Dist., 132 F.3d 902, 906 n.8 (3d Cir. 1997). The primary question in deciding a motion to dismiss is not whether the plaintiff will ultimately prevail; but rather, whether he or she is entitled to offer evidence to establish the facts alleged in the complaint. Maio v. Aetna, 221 F.3d 472, 482 (3d Cir. 2000). The purpose of a motion to dismiss is to “streamline[] litigation by dispensing with needless discovery and factfinding.” Neitzke v. Williams, 490 U.S. 319, 326-27 (1989). Furthermore, “in evaluating a motion to dismiss, courts are not limited to the complaint, but may also consider evidence integral to or explicitly relied upon therein.” Tanksley v. Daniels, 902 F.3d 165, 172 (3d Cir. 2018) (internal quotations omitted). “In deciding a Rule 12(b)(6) motion, a court must consider only the complaint, exhibits attached to the complaint, matters of public record, as well as undisputedly authentic documents if the complainant’s claims are based

upon these documents.” Mayer v. Belichick, 605 F.3d 223, 230 (3d Cir. 2010) (citation omitted). III. Discussion A. PHRA Disparate Treatment Claim Takeda argues that Ms. Andres fails to plead sufficient facts to establish a disparate treatment claim under the PHRA, because Ms. Andres does not plead any facts suggesting that Ms. Andres’ religion had anything to do with her termination. (ECF No. 12, at 8). Ms. Andres argues

that she pleads sufficient facts to establish a disparate treatment claim under the PHRA. (ECF No. 13, at 2-4). To establish a disparate treatment claim based upon religion, Plaintiff “must show that [she was] singled out and treated less favorably than others similarly situated on the basis of [her] religious beliefs.” Doe(s) v. Pittsburgh Reg’l Transit, 684 F. Supp. 3d 417, 429 (W.D. Pa. 2023) (quoting White v. Gallagher Bassett Servs., 257 F. Supp. 2d 804, 808 (E.D. Pa. 2003)).1 That is, Plaintiff “must demonstrate that … nonmembers of the protected class were treated more

favorably” than she was.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Neitzke v. Williams
490 U.S. 319 (Supreme Court, 1989)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
Francis J. Kelly v. Drexel University
94 F.3d 102 (Third Circuit, 1996)
Morse v. Lower Merion School District
132 F.3d 902 (Third Circuit, 1997)
LeBoon v. Lancaster Jewish Community Center Ass'n
503 F.3d 217 (Third Circuit, 2007)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
White v. GALLAGHER BASSETT SERVICES
257 F. Supp. 2d 804 (E.D. Pennsylvania, 2003)
Elias Eid v. John Thompson
740 F.3d 118 (Third Circuit, 2014)
Patricia Thompson v. Real Estate Mortgage Network
748 F.3d 142 (Third Circuit, 2014)
Moore v. City of Philadelphia
461 F.3d 331 (Third Circuit, 2006)
Lauren W. Ex Rel. Jean W. v. Deflaminis
480 F.3d 259 (Third Circuit, 2007)
Sandra Connelly v. Lane Construction Corp
809 F.3d 780 (Third Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
ANDRES v. TAKEDA PHARMACEUTICALS AMERICA, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/andres-v-takeda-pharmaceuticals-america-inc-pawd-2024.